Skip to main content
Premium Trial:

Request an Annual Quote

David King, James Henson, Patricia Forbes

Premium
David King Joins Quaker BioVentures
 
Quaker BioVentures has hired David King as a venture partner.
 
King has served as CEO of three venture-backed life science companies and led them to acquisitions by large pharmaceutical companies.
 
King was a founder and CEO of BioRexis Pharmaceutical, which was acquired by Pfizer in 2007. Previously, he served as the CEO of Principia Pharmaceutical Corporation, which was acquired by Human Genome Sciences. Prior to that, he was president of Delsys Pharmaceutical, which was acquired by Elan.
 
King also previously served as a director of Cephalon, 3-Dimensional Pharmaceuticals, and Morphotek.
 
He is currently a consultant to biotechnology companies and serves as chairman of Xencor.
 

 
UN Reno’s Henson Tapped to Help DoD Select Research Projects
 
The Nevada System of Higher Education Research Affairs Council has selected James Henson, associate chair of the University of Nevada, Reno’s electrical and biomedical engineering department, as the project director for a federally funded research program.
 
Henson will lead the Department of Defense Experimental Program to Stimulate Competitive Research, or DEPSCoR, a program intended to increase research competitiveness in states that historically have not received significant R&D funding from DoD agencies.
 
Nevada is one of 25 states and two territories authorized to participate in the program.
 
According to NSHE, Nevada DEPSCoR programs have totaled more than $4 million and the state has matched more than $2 million in research funding.
 

 
Patricia Forbes Joins Relocation Management Firm DPM
 
Diversified Project Management, a consulting firm that specializes in corporate relocations, has hired Patricia Forbes as project executive.
 
DPM is an owners' representative firm and provides programming, project management, construction administration, furniture coordination, and move-planning services.
 
Forbes will work from DPM's headquarters in Newton, Mass.
 
Prior to joining DPM, she was vice president of development services for Paradigm Properties in Boston. She also worked as project director for the Artery Business Committee and served as vice president of real estate for ChildrenFirst.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.